64/100B39.440
USD
-0.54
(-1.35%)
Market Closed
Last updated: · Delayed 15 min
Medline net income 2022–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Medline earned 195.00M USD in Q3 FY2026, the three months to 26 September 2026, down 39.4% on the same quarter a year before. Medline earned a net income of 1.16B USD in fiscal year 2025, down 3.4% on the year before.
Last updated 9 Nov 2026 · Next report 24 Feb 2027
Net income
Net income Net margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 26 Sept 2026 | 564.00M | — | 1.84% | 30.68B |
| FY2025 | 31 Dec 2025 | 1.16B | -3.42% | 4.08% | 28.43B |
| FY2024 | 31 Dec 2024 | 1.20B | +412.82% | 4.70% | 25.51B |
| FY2023 | 31 Dec 2023 | 234.00M | — | 1.01% | 23.23B |
| FY2022 | 31 Dec 2022 | -25.00M | — | -0.12% | 21.45B |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 195.00M | -39.44% | 2.48% | 7.86B |
| Q2 FY2026 | 27 Jun 2026 | 60.00M | -81.98% | 0.78% | 7.69B |
| Q1 FY2026 | 31 Mar 2026 | 129.00M | -59.94% | 1.75% | 7.35B |
| Q4 FY2025 | 31 Dec 2025 | 180.00M | — | 2.31% | 7.79B |
| Q3 FY2025 | 30 Sept 2025 | 322.00M | -0.62% | 4.53% | 7.12B |
| Q2 FY2025 | 30 Jun 2025 | 333.00M | +14.04% | 4.84% | 6.89B |
| Q1 FY2025 | 31 Mar 2025 | 322.00M | — | 4.85% | 6.64B |
| Q3 FY2024 | 30 Sept 2024 | 324.00M | — | 5.07% | 6.39B |
| Q2 FY2024 | 30 Jun 2024 | 292.00M | — | 4.72% | 6.19B |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about Medline's profit
Source: Financial Modeling Prep